Pleurisy that arises in the setting of suspected drug-induced pleuritis or drug-induced lupus pleuritis represents a distinct clinical scenario requiring a targeted management approach that differs from other causes of pleural inflammation.
This protocol applies when pleurisy is encountered in a patient where drug-induced pleuritis or drug-induced lupus pleuritis is the suspected underlying aetiology.
If a patient has suspected drug-induced pleuritis or drug-induced lupus pleuritis, the causal agent should be discontinued.
View source ↗